CCRB Logo

Trial Detail

CUHK_CCT00113

2006-08-31

Prospective

Nil

MSD

Prof. Albert Martin Li

Dr. Victor Abdullah

Tracy Tsen

6/F, Department of Paediatric, Clinical Science Building, Prince of Wales Hospital, Shatin, N/T

Tel., 26324304, fax, 26360020

email, tracy-tsen@cuhk.edu.hk

Tracy Tsen

Prof. A.M Li

6/F, Department of Paediatric, Clinical Science Building, Prince of Wales Hospital, Shatin, N/T

Tel., 26322982

e-mail, albertmli@cuhk.edu.hk

Prof. A.M Li

Use of Leukotriene Receptor Antagonist in the Treatment of Allergic Rhinitis

Receptor Antagonist in the Treatment of Allergic Rhinitis

Nil

Hong Kong

Yes

2006-05-18

asthma, allergic rhinitis

Drug

Montelukast

26 weeks per subject

N/A

Include: Patient from 6-18 yrs old with asthma and allergic rhinitis

Exclude: Subject with congenital nasal anomalies or had received systemically administered corticosteroids within 1 month of enrollment.

6

18

Both Male and Female

Interventional

Randomized

Placebo

Double-blind

Parallel

2006-10-01

46

Complete

The primary outcome measures include nasal cytokine levels, nasal airflow and daily rhinitis scores.

Secondary outcomes measures include symptom-free days, blood eosinophil counts and spirometric parameters.

No

2009-11-26

ChiCTR-TRC-09000688

2010-05-04

Type Document Published On  
No documents yet.
  • Page 1 of 1.